The first COPD patient has been dosed in a Phase 1b COPD trial testing Bambusa Therapeutics’ dual-target therapy BBT002.
Columnist Caroline Gainer remembers a horseback ride that taught her a lesson about how to respond when you find yourself ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback